aspect of
doctor)
→
ReceivesAction
→
enrolled in the study
| Typicality: | 0.523 |
| Saliency: | 0.436 |
| of a new lung cancer treatment | 6 | other |
| for a period of 4 months | 4 | temporal |
| patient → be enrolled in → the study | 18 |
| patient → be enrolled in → study | 8 |
| patient → be enrolled in → this study | 4 |
| patient → enroll in → study | 3 |
| patient → be enrolled into → the study | 3 |
| negative | neutral | positive |
| 0.223 | 0.686 | 0.091 |
| Raw frequency | 36 |
| Normalized frequency | 0.436 |
| Modifier score | 0.767 |
| Perplexity | 73.279 |